期刊文献+

经阴道三维超声造影对宫腔内良恶性病变及微血管密度的诊断价值 被引量:5

Diagnostic value of transvaginal three-dimensional ultrasound in benign and malignant lesions and micro vessel density in uterine cavity
原文传递
导出
摘要 目的探究经阴道三维超声造影对宫腔内良恶性病变及其与微血管密度的临床应用。方法 80例患者均通过手术获得组织病理学结果,分为良性组(42例)、交界性组(12例)和恶性变组(26例),经阴道三维超声造影检测患者病情,分析该方法对宫腔内良恶性病变及其与微血管密度的诊断价值。结果良性组、交界性组、恶性组的达峰时间、增强强度、AUC值、MVD分别为(16.12±2.08)s、(13.56±1.32)d B、(1 453.96±87.24)d B.s、(14.56±7.12);(14.92±1.63)s、(14.29±1.96)d B、(1 501.38±81.82)d B.s、(21.76±7.28);(13.51±1.42)s、(14.96±2.02)d B、(1 552.13±79.44)d B.s、(37.42±18.53)。结论经阴道三维超声造影可显著区分恶性病变、交界性病变和良性病变,达峰时间和MVD水平是鉴别宫腔内良恶性病变的较好指标。 Objective To explore the diagnostic value of transvaginal three-dimensional ultrasound in benign and malignant lesions and micro vessel density in uterine cavity. Methods We selected 80 patients whose pathological results were tested then were divided into benign group (n=42) , borderline group (n= 12) and malignant group (n=26). Patients were detected by transvaginal three-dimensional ultrasound so as to analyze the diagnostic value of transvaginal three-dimensional ultrasound. Results The peak time, enhancement intensity, AUC value, and MVD of benign group, borderline group, malignant group were (16.12±2.08)s, (13.56±1.32)dB, (1 453.96±87.24)riB. s, (14.56±7.12);(14.92±1.63)s, (14.29±1.96)dB, (1 501.38 ± 81. 82) dB. s, (21. 76±7. 28); (13. 51±1. 42) s, (14.96±2.02) dB, (1 552. 13±79. 44) dB. s, (37.42±18.53). Conclusion Transvaginal three-dimensional ultrasound can distinguish malignant lesions, borderline lesions and benign lesions significantly. Peak time and the MVD level are good indexes to identify benign and malignant lesions in the uterine cavity.
出处 《中国地方病防治》 CAS 北大核心 2016年第7期736-737,共2页 Chinese Journal of Control of Endemic Diseases
基金 新疆维吾尔自治区自然科学基金项目(2013211A085)
关键词 三维超声 超声造影 宫腔病变 微血管密度 Three-dimensional ultrasound Contrast enhanced ultrasound Uterine cavity lesion Micro vessel density
作者简介 周慧丽(女),硕士,主治医师,主要从事妇科超声工作。通讯作者:周慧丽,E—mail:1539915591@qq.com
  • 相关文献

参考文献2

二级参考文献26

  • 1王春美.三维超声成像技术的原理及临床应用[J].南方医科大学学报,2001,25(S1):66-68. 被引量:12
  • 2赵敏,王诚,刘智,韩金兰,严敬明,常才.经阴道彩色多普勒超声对体外受精-胚胎移植子宫内膜容受性的评估价值[J].中华超声影像学杂志,2007,16(8):699-702. 被引量:16
  • 3张新玲,郑荣琴,黄冬梅,张波,李凯.低机械指数连续超声造影在宫颈癌中的应用探讨[J].中国超声医学杂志,2007,23(11):852-855. 被引量:16
  • 4Farquhar C,Brosens. Medical and surgical management of adenomyosis[J]. Best Prat Res Clin Obstet Gynaecol, 2006,20(4) :603-616.
  • 5Ishihara H, Kitawaki J, Kado N, et al. Gonadotropinre- leasing hormone agonist and danazol normalize aromatase eytochrome P450 expression in eutopie endometirum from women with endometirosis, adenomyosis, or leio- myomas[J]. Fetril Steril, 2004,79 Suppl 1 : 735-742.
  • 6Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyo- sis:the clinical experience of a single center[J]. Fertil Steril, 2011 ( 3), 900-905.
  • 7Fan TY, Zhang L, Chen W, et al. Feasibility of MRI- guided high intensity focused ultrasound treatment for adenomyosis[J]. Eur J Radiol, 2012,81 ( 11 ): 3624-3630.
  • 8Dong X, Yang Z. High-intensity focused ultrasound abla- tion of uterine localized adenomyosis[J]. Curt Opin Ob- stet Gynecol, 2010,22 : 326-330.
  • 9Orsi F,Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations[J]. AJR Am J Roentgenol, 2010,195(3) :245-252.
  • 10Moschouris H, Malagari K, Kornezos I, et al. Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads[J]. Cardiovasc Intervent Radiol,2010, 33(6): 1215-1222.

共引文献34

同被引文献42

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部